Eugeniy P Smorodin (Eugeniy Smorodin)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Venues

Current oncology (Toronto, Ont.)

Disease markers

International journal of molecular sciences

National Institute for Health Development

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Institute for Health Development Jan 01 1979

Estonia

Diagnostic/prognostic role of antibodies to tumor gycans :: Oncology & Immunology

Publications

Eugeniy P Smorodin, Valentin Chuzmarov, Toomas Veidebaum
The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and a Literature Review. Current oncology (Toronto, Ont.) 31 (4) (2024)
Eugeniy P Smorodin, Valentin Chuzmarov, Toomas Veidebaum
The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and a Literature Review. Current oncology (Toronto, Ont.) 31 (4) (2024)
Eugeniy P Smorodin, Valentin Chuzmarov, Toomas Veidebaum
The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and a Literature Review. Current oncology (Toronto, Ont.) 31 (4) (2024)
Eugeniy P Smorodin, Valentin Chuzmarov, Toomas Veidebaum
The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and a Literature Review. Current oncology (Toronto, Ont.) 31 (4) (2024)
Eugeniy P Smorodin, Valentin Chuzmarov, Toomas Veidebaum
The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and a Literature Review. Current oncology (Toronto, Ont.) 31 (4) (2024)
Eugeniy P Smorodin
Prospects and Challenges of the Study of Anti-Glycan Antibodies and Microbiota for the Monitoring of Gastrointestinal Cancer. International journal of molecular sciences 22 (21) (2021)
Eugeniy P Smorodin, Boris Sergeyev, Oleg Kurtenkov, Tatiana Kuznetsova, Julia Geller
IgG Antibodies to GlcNAcβ and Asialo-GM2 (GA2) Glycans as Potential Markers of Liver Damage in Chronic Hepatitis C and the Efficacy of Antiviral Treatment. Disease markers 2018 (2018)

Eugeniy P Smorodin.css-eqlu8i{font-size:small;padding-left:4px;} (Eugeniy Smorodin)

Publication Activity (10 Years)

Top Topics

Top Venues

Eugeniy P Smorodin (Eugeniy Smorodin)